Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong · Delayed Price · Currency is HKD
17.10
0.00 (0.00%)
At close: Jan 23, 2026
HKG:3378 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
|---|
| -115.83 | -76.06 |
Depreciation & Amortization | 5.37 | 1.01 |
| 0.11 | 0.03 |
Loss (Gain) From Sale of Investments | -1.62 | 33.1 |
| 22.35 | 15.49 |
Other Operating Activities | -7.28 | -20.62 |
Change in Accounts Payable | -0.64 | 0.88 |
Change in Other Net Operating Assets | -7.35 | -5.83 |
| -104.89 | -51.99 |
| -6.21 | -4.23 |
Sale (Purchase) of Intangibles | - | -0.55 |
| 99.91 | 94.63 |
Other Investing Activities | 2.92 | 4.11 |
| 96.62 | 93.96 |
| -3.81 | -1.16 |
| -3.81 | -1.16 |
| 12.84 | 91.38 |
Other Financing Activities | -2.55 | - |
| 6.49 | 90.22 |
Foreign Exchange Rate Adjustments | 1 | 0.03 |
| -0.79 | 132.21 |
| -111.1 | -56.23 |
| -5052.48% | -2214.49% |
| -10.16 | -7.71 |
| 5.81 | 2.05 |
| 101.65 | - |
| 107.51 | - |
Change in Working Capital | -7.99 | -4.95 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.